MY176214A - Three-pack type dialysis agent containing acetic acid and acetic acid salt - Google Patents

Three-pack type dialysis agent containing acetic acid and acetic acid salt

Info

Publication number
MY176214A
MY176214A MYPI2016701187A MYPI2016701187A MY176214A MY 176214 A MY176214 A MY 176214A MY PI2016701187 A MYPI2016701187 A MY PI2016701187A MY PI2016701187 A MYPI2016701187 A MY PI2016701187A MY 176214 A MY176214 A MY 176214A
Authority
MY
Malaysia
Prior art keywords
acetic acid
agent
pack type
dialysis fluid
bicarbonate
Prior art date
Application number
MYPI2016701187A
Inventor
Hiroshi Noguchi
Michiko Myose
Junya Kikuishi
Hideyuki Aoyama
Mina Hashimoto
Yusuke Yoshimoto
Original Assignee
Tomita Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomita Pharma filed Critical Tomita Pharma
Publication of MY176214A publication Critical patent/MY176214A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor

Abstract

The purpose of the present invention is to provide a three-pack type dialysis agent with which it is possible to set the total acetic acid ion content in a dialysis fluid at a low value and which is excellent in terms of the storage stability of glucose, etc. and can be reduced in the odor of acetic acid. Therewith, it is possible to prepare a dialysis fluid so that the bicarbonate ion concentration can be changed at will according to need, while the concentrations of trace metal ions such as potassium ions, calcium ions, and magnesium ions are kept constant. The three-pack type dialysis agent comprises agent S comprising sodium chloride, agent B comprising sodium bicarbonate, and agent A containing glucose and an electrolyte ingredient which is neither sodium chloride nor sodium bicarbonate. By making the agent A contain acetic acid and an acetic acid salt and satisfy that the molar ratio of acetic acid/acetic acid salt is 1/(0.5-2), a bicarbonate dialysis fluid having a total acetic acid ion concentration of 2 mEq/L or higher but less than 6 mEq/L can be prepared. This agent A not only is excellent in terms of the stability of the ingredients including glucose but also can be reduced in the odor of acetic acid. According to the three-pack type dialysis agent, by controlling the amounts of the agents S, B, and A to be added when preparing a dialysis fluid, the bicarbonate ion concentration and/or sodium concentration in the dialysis fluid can be also changed.
MYPI2016701187A 2013-10-02 2014-10-02 Three-pack type dialysis agent containing acetic acid and acetic acid salt MY176214A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013207382A JP5517322B1 (en) 2013-10-02 2013-10-02 Three-part dialysis agent containing acetic acid and acetate
PCT/JP2014/076373 WO2015050189A1 (en) 2013-10-02 2014-10-02 Three-pack type dialysis agent containing acetic acid and acetic acid salt

Publications (1)

Publication Number Publication Date
MY176214A true MY176214A (en) 2020-07-24

Family

ID=51031258

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI2016701186A MY178249A (en) 2013-10-02 2014-10-02 Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same
MYPI2016701187A MY176214A (en) 2013-10-02 2014-10-02 Three-pack type dialysis agent containing acetic acid and acetic acid salt

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MYPI2016701186A MY178249A (en) 2013-10-02 2014-10-02 Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same

Country Status (6)

Country Link
JP (1) JP5517322B1 (en)
KR (1) KR102363179B1 (en)
MY (2) MY178249A (en)
PH (1) PH12016500571A1 (en)
SG (1) SG11201602533QA (en)
WO (1) WO2015050189A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5376480B1 (en) 2012-10-10 2013-12-25 富田製薬株式会社 A dialysis agent containing acetic acid and acetate, and two-agent dialysis agent using the same
JP5517321B1 (en) 2013-10-02 2014-06-11 富田製薬株式会社 Solid dialysis agent A containing alkali metal diacetate, and two-agent type low-acetate dialysis agent using the same
WO2015072494A1 (en) 2013-11-12 2015-05-21 扶桑薬品工業株式会社 Novel sodium diacetate crystal and solid dialysis preparation comprising said crystal
JP6562336B2 (en) * 2014-12-11 2019-08-21 富田製薬株式会社 Method for producing granulated material used for dialysis agent A
WO2016156502A1 (en) * 2015-03-31 2016-10-06 Gambro Lundia Ab A package for an acidic dialysis fluid concentrate containing citrate and glucose
JP6467285B2 (en) * 2015-05-13 2019-02-13 富田製薬株式会社 Granules for agent A for dialysis and method for producing the same
CN109890370B (en) * 2016-10-28 2021-06-29 富田制药株式会社 Agent A for hemodialysis
JP6312957B1 (en) * 2016-10-28 2018-04-18 富田製薬株式会社 Agent A for hemodialysis
CN110522763A (en) * 2019-10-08 2019-12-03 四川太平洋药业有限责任公司 A kind of Multiple electrolytes injection and preparation process

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0599464A (en) 1991-10-08 1993-04-20 Nec Corp Air shower device
ES2149793T5 (en) 1993-02-19 2005-03-01 Wilfried Dr.-Ing. Schal PROCEDURE FOR THE PREPARATION OF BICARBONATED DIALIZER LIQUID FOR HEMODIALISIS.
JP2809971B2 (en) 1993-07-06 1998-10-15 扶桑薬品工業株式会社 Hemodialysis preparation
JP3433979B2 (en) * 1993-08-24 2003-08-04 日機装株式会社 Dialysis agent and method for producing the same
JP3619921B2 (en) 1996-09-13 2005-02-16 富田製薬株式会社 Bicarbonate solid dialysis agent
CN1152668C (en) * 1997-08-22 2004-06-09 清水制药株式会社 Glucose-contg. preparation
JP3586767B2 (en) * 2000-04-06 2004-11-10 富田製薬株式会社 Preparation method and adjustment device for dialysate
JP5204359B2 (en) 2001-09-28 2013-06-05 味の素株式会社 Dialysis agent and method for producing the same
CN1189180C (en) * 2003-04-30 2005-02-16 广州康盛生物科技有限公司 Bicarbonate dry powder composition for hemodialysis
JPWO2005094918A1 (en) 2004-03-30 2008-02-14 ニプロ株式会社 Dialysis solid preparation
WO2010112570A1 (en) 2009-03-31 2010-10-07 Gambro Lundia Ab Dialysis solution
JP5099464B1 (en) * 2011-12-29 2012-12-19 富田製薬株式会社 Bicarbonate ion concentration-variable dialysate preparation device and preparation method, bicarbonate ion concentration-variable dialysate, and bicarbonate ion concentration-variable dialyzing system

Also Published As

Publication number Publication date
MY178249A (en) 2020-10-07
KR102363179B1 (en) 2022-02-14
KR20160064181A (en) 2016-06-07
JP2015070908A (en) 2015-04-16
SG11201602533QA (en) 2016-05-30
PH12016500571B1 (en) 2016-06-20
PH12016500571A1 (en) 2016-06-20
JP5517322B1 (en) 2014-06-11
WO2015050189A1 (en) 2015-04-09

Similar Documents

Publication Publication Date Title
PH12016500571A1 (en) Three-pack type dialysis agent containing acetic acid and acetic acid salt
PH12015500702B1 (en) Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same
WO2011161056A3 (en) Dialysis precursor composition
MY185528A (en) Silver powder, method for producing silver powder, and conductive paste
WO2008111358A1 (en) Composition for stabilizing chlorine dioxide
PH12016500572A1 (en) Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same
RU2013156999A (en) COMPOSITIONS FOR CARE FOR THE ORAL EMPLOYMENT CONTAINING PHYTIC ACID
ZA202210899B (en) Solutons for increasing the stability and shelf life of an organ and tissue preservation solution
PE20140870A1 (en) HERBICIDE GRANULES WITH INTEGRATED ADJUVANT
NZ605147A (en) Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
RU2011109191A (en) ANTI-MICROBIAL SILVER SOLUTIONS
WO2009041267A1 (en) Bactericidal/algicidal method
ZA201504284B (en) Solution for preserving vascular conduits
HRP20210234T1 (en) Formulations for stabilizing moisture in muscle foods
MX2015016424A (en) Aqueous solutions containing a complexing agent in high concentration.
MX2019003520A (en) Mixtures and formulations comprising an alkyl ammonium edta salt.
NZ599377A (en) Salts, aqueous liquid compositions containing salts of S-(+)-abscisic acid and methods of their preparation
WO2019004770A3 (en) Oral solid preparation composition comprising proton pump inhibitor, oral solid preparation comprising same, and preparation method therefor
MY176112A (en) Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol
ZA202004218B (en) Aqueous composition as electrolyte comprising ionic liquids or lithium salts
MY163015A (en) Dentifrice composition
PH22012000673U1 (en) Anhydrous antiperspirant compositions
TH1601001852A (en) Three-pack dialysis agents with acetic acid And acetic acid salts
RU2013115268A (en) ACID DIALYSIS CONCENTRATE
CN102783483A (en) 3-isothiazolinone composition